Nanoengineering bactericidal nitric oxide therapies

Virulence

Volumn 2, Issue 3, 2011, Pages

  Cabrales, Pedro ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GOLD NANOPARTICLE; NANOPARTICLE; NITRIC OXIDE;

ANTIBACTERIAL ACTIVITY; BACILLUS SUBTILIS; BACTERIAL GROWTH; EDITORIAL; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HYDROGEL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MULTIDRUG RESISTANCE; NANOENGINEERING; NONHUMAN; OXIDATIVE STRESS; WOUND CLOSURE; WOUND INFECTION;

EID: 85011941660     PISSN: 21505594     EISSN: 21505608     Source Type: Journal    
DOI: 10.4161/viru.2.3.16746     Document Type: Editorial

References (15)

1. Zacharia IG, Deen WM. Diffusivity and solubility of nitric oxide in water and saline. Ann Biomed Eng 2005; 33:214-222.
2. Garthwaite J, Charles SL, Chess-Williams R. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature 1988; 336:385-388.
3. Moncada S, Palmer MJ, Higgs EA. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43:109-134.
4. Gusarov I, Starodubtseva M, Wang ZQ, McQuade L, Lippard SJ, Stuehr DJ, et al. Bacterial nitric-oxide synthases operate without a dedicated redox partner. J Biol Chem 2008; 283:13140-13147.
5. Poole RK. Nitric oxide and nitrosative stress tolerance in bacteria. Biochem Soc Trans 2005; 33:176-180.
6. Adak S, Aulak KS, Stuehr DJ. Direct evidence for nitric oxide production by a nitric-oxide synthase-like protein from Bacillus subtilis. J Biol Chem 2002; 277:16167-16171.
7. Gusarov I, Shatalin K, Starodubtseva M, Nudler E. Endogenous nitric oxide protects bacteria against a wide spectrum of antibiotics. Science 2009; 325:1380-1384.
8. Richter C, Gogvadze V, Laffranchi R, Schlapbach R, Schweizer M, Suter M, et al. Oxidants in mitochondria: from physiology to diseases. Biochim Biophys Acta 1995; 1271:67-74.
9. Hendriks J, Oubrie A, Castresana J, Urbani A, Gemeinhardt S, Saraste M. Nitric oxide reductases in bacteria. Biochim Biophys Acta 2000; 1459:266-273.
10. Friedman A, Friedman J. New biomaterials for the sustained release of nitric oxide: past, present and future. Expert Opin Drug Deliv 2009; 6:1113-1122.
11. Friedman AJ, Han G, Navati MS, Chacko M, Gunther L, Alfieri A, et al. Sustained release nitric oxide releasing nanoparticles: characterization of a novel delivery platform based on nitrite containing hydrogel/glass composites. Nitric Oxide 2008; 19:12-20.
12. Navati MS, Friedman JM. Sugar-derived glasses support thermal and photo-initiated electron transfer processes over macroscopic distances. J Biol Chem 2006; 281:36021-36028.
13. Han G, Martinez LR, Mihu MR, Friedman AJ, Friedman JM, Nosanchuk JD. Nitric oxide releasing nanoparticles are therapeutic for Staphylococcus aureus abscesses in a murine model of infection. PLoS One 2009; 4:e7804.
14. Martinez LR, Han G, Chacko M, Mihu MR, Jacobson M, Gialanella P, et al. Antimicrobial and healing efficacy of sustained release nitric oxide nanoparticles against Staphylococcus aureus skin infection. J Invest Dermatol 2009; 129:2463-2469.
15. Friedman A, Blecher K, Sanchez D, Tuckman-Vernon C, Gialanella P, Friedman JM, et al. Susceptibility of Gram-positive and -negative bacteria to novel nitric oxide-releasing nanoparticle technology. Virulence 2011; In press.